Table 9.

Percent of oropharyngeal swallowing disorders and other measures of swallowing observed in the 19 patients with oropharyngeal cancer treated with chemoradiation at pretreatment (baseline) and 3 and 12 mo posttreatment.

	Baseline, %	Posttreatment		Overall p value by Cochran's Q	Pairwise p value by McNemar's
		3 mo, %	12 mo, %		Baseline vs 3 mo	Baseline vs 12 mo	3 vs 12 mo
Description of disorder
Reduced tongue base retraction	68	100	84	<.0001	No test	.26	No test
Reduced tongue strength	44	67	72	.12	.10	.06	.71
Delayed pharyngeal swallow	37	63	53	.12	.06	.26	.32
Slowed/delayed vestibule closure	26	68	63	.013	.01	.02	.71
Reduced tongue control	37	47	32	.42	.16	.71	.26
Reduced A-P tongue movement	47	47	58	.51	.99	.41	.16
Reduced laryngeal elevation	5	21	26	.16	.08	.10	.65
Reduced tongue stabilization	28	17	17	.45	.32	.32	.99
Bilateral pharyngeal weakness	5	32	32	.06	.03	.03	.99
Reduced cricopharyngeal opening	0	21	16	.11	No test	No test	.65
Visible cricopharyngeal bar	5	21	5	.22	.18	.99	.18
Incomplete laryngeal vestibule closure	0	11	11	.37	No test	No test	.99
Other measures of swallowing
Functional swallow	95	74	84	.14	.05	.32	.32
% Oral intake <50%	5	32	11	.015	.025	.32	.046
% Normal diet	84	53	58	.045	.034	.025	.71
Mean saliva weight (in grams)	5.31	0.65	0.93	<.0001	<.0001	<.0001	.16
SEM	0.52	0.08	0.18

Abbreviations: SEM, standard error of the mean; A-P, anterior-posterior.

Note: Bolded values indicate p < .05 for overall test or p < .017 for pairwise test. (“No test” means frequencies were too low to perform statistical tests).